Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Long-chain 3-hydroxy acyl-CoA dehydrogenase

Trifunctional Protein and Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiencies... [Pg.2232]

Fig. 23.1 Body composition and lipid deposition. Data are presented as means SD. (a) There is a trend for long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD)-deficient patients (n = 9 closed bars) to have less fat-free mass and more fat mass compared with control subjects (n = 9 open bars) when expressed as %body mass, (b) There was no difference in fat-free or fat mass expressed as mass/surface area between groups, (c) There was a trend for LCHAD-deficient patients (n = 9 closed bars) to have more extramyocellular Upid EMCL) but no difference in intramyocellular lipid IMCL) compared with... Fig. 23.1 Body composition and lipid deposition. Data are presented as means SD. (a) There is a trend for long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD)-deficient patients (n = 9 closed bars) to have less fat-free mass and more fat mass compared with control subjects (n = 9 open bars) when expressed as %body mass, (b) There was no difference in fat-free or fat mass expressed as mass/surface area between groups, (c) There was a trend for LCHAD-deficient patients (n = 9 closed bars) to have more extramyocellular Upid EMCL) but no difference in intramyocellular lipid IMCL) compared with...
Gillingham MB, et al. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab. 2006 89(l-2) 58-63. [Pg.282]

Long-chain 3-hydroxy-acyl-CoA dehydrogenase-a/ deficiency 14.8... [Pg.683]

Figure 55-14 Plasma profiles of plasma acylcarnitine butyl-ester derivatives. A, Normal control. B, Propionic acidemia. C, Short-chain acyl-CoA dehydrogenase deficiency. D, Isovaleric acidemia. E, Medium-chain acyl-CoA dehydrogenase deficiency. F, Very long-chain acyl-CoA dehydrogenase deficiency. G, Long-chain L-3-hydroxy acyl-CoA dehydrogenase deficiency.The symbol marks internal standards [ Hjj-acetylcarnitine (m/z 263) [ HaJ-propionylcarnitine (m/z 277) fH ]-butyrylcarnitlne (m/z 295) pHal-octanoylcarnitine (m/z 347) [ Haj-dodecanoylcarnltine (m/z 403) [ Haj-palmitoy I carnitine (m/z 459). Figure 55-14 Plasma profiles of plasma acylcarnitine butyl-ester derivatives. A, Normal control. B, Propionic acidemia. C, Short-chain acyl-CoA dehydrogenase deficiency. D, Isovaleric acidemia. E, Medium-chain acyl-CoA dehydrogenase deficiency. F, Very long-chain acyl-CoA dehydrogenase deficiency. G, Long-chain L-3-hydroxy acyl-CoA dehydrogenase deficiency.The symbol marks internal standards [ Hjj-acetylcarnitine (m/z 263) [ HaJ-propionylcarnitine (m/z 277) fH ]-butyrylcarnitlne (m/z 295) pHal-octanoylcarnitine (m/z 347) [ Haj-dodecanoylcarnltine (m/z 403) [ Haj-palmitoy I carnitine (m/z 459).
Fig. 8. P-Oxidation of fatty acids in E. coli. Long-chain fatty acids are transported into the cell by FadL and converted to their CoA thioesters by FadD (not shown). The acyl-CoAs are substrates for the (1) acyl-CoA dehydrogenase (YafH) to form a trans-2-enoyl-CoA. The double bond is reduced by (2) rrans-2-enoyl-hydratase (crotonase) activity of FadB. The P-hydroxyacyl-CoA is then a substrate for the NADP -dependent dehydrogenase activity of FadB (3). A thiolase, FadA (4), releases acetyl-CoA from the P-ketoacyl-CoA to form an acyl-CoA for subsequent cycles. (5) Polyunsaturated fatty acyl-CoAs are reduced by the 2,4-dienoyl-CoA reductase (FadH). (6) FadB also catalyzes the isomerization of c/s-unsaturated fatty acids to trans. (7) The epimerase activity of FadB converts O-P-hydroxy thioesters to their L-enantiomers via the /rans-2-enoyl-CoA. Fig. 8. P-Oxidation of fatty acids in E. coli. Long-chain fatty acids are transported into the cell by FadL and converted to their CoA thioesters by FadD (not shown). The acyl-CoAs are substrates for the (1) acyl-CoA dehydrogenase (YafH) to form a trans-2-enoyl-CoA. The double bond is reduced by (2) rrans-2-enoyl-hydratase (crotonase) activity of FadB. The P-hydroxyacyl-CoA is then a substrate for the NADP -dependent dehydrogenase activity of FadB (3). A thiolase, FadA (4), releases acetyl-CoA from the P-ketoacyl-CoA to form an acyl-CoA for subsequent cycles. (5) Polyunsaturated fatty acyl-CoAs are reduced by the 2,4-dienoyl-CoA reductase (FadH). (6) FadB also catalyzes the isomerization of c/s-unsaturated fatty acids to trans. (7) The epimerase activity of FadB converts O-P-hydroxy thioesters to their L-enantiomers via the /rans-2-enoyl-CoA.

See other pages where Long-chain 3-hydroxy acyl-CoA dehydrogenase is mentioned: [Pg.174]    [Pg.189]    [Pg.2232]    [Pg.270]    [Pg.174]    [Pg.189]    [Pg.2232]    [Pg.270]    [Pg.174]    [Pg.137]    [Pg.332]    [Pg.332]    [Pg.262]    [Pg.360]    [Pg.181]    [Pg.366]    [Pg.474]    [Pg.291]    [Pg.475]   


SEARCH



3-hydroxy acylation

4(5>Acyl-2-hydroxy

Acyl dehydrogenase

Acyl long-chain

Acyl-CoA

Acyl-CoA dehydrogenase

Acyl-CoA dehydrogenases

Hydroxy dehydrogenase

Hydroxy-acyl CoA dehydrogenase

Long-chain 3-hydroxy acyl-CoA dehydrogenase deficiency

Long-chain acyl CoA

Long-chain acyl-CoA dehydrogenase

© 2024 chempedia.info